Catalyst Capital Advisors’s Boston Scientific BSX Stock Holding History

Catalyst Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,021	Closed	-$193K	–	374
2025 Q4	$193K	Sell	2,021 -1,020	-34%	-$100K	﹤0.01%	228
2025 Q3	$297K	Buy	3,041 +774	+34%	+$80.2K	0.01%	201
2025 Q2	$243K	Buy	2,267 +687	+43%	+$69.5K	﹤0.01%	230
2025 Q1	$159K	Buy	1,580 +492	+45%	+$49.5K	﹤0.01%	254
2024 Q4	$97.2K	Buy	+1,088	New	+$95.8K	﹤0.01%	297
2015 Q1	–	Sell	-1,080,000	Closed	-$14.3M	–	452
2014 Q4	$14.3M	Buy	+1,080,000	New	+$13.8M	1.68%	12

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Catalyst Capital Advisors's BSX Position: Q1 2026 in Review

Catalyst Capital Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,021 shares — an estimated $193K sold.

Catalyst Capital Advisors first reported a position in BSX in Q4 2014 and held it in 6 quarters. The position peaked at $14.3M in Q4 2014. 1,679 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Catalyst Capital Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Catalyst Capital Advisors sold 2,021 Boston Scientific shares in Q1 2026, an estimated $193K.
Catalyst Capital Advisors first reported a position in Boston Scientific in Q4 2014 and held it in 6 quarters.
Catalyst Capital Advisors's Boston Scientific position peaked at $14.3M in Q4 2014.
1,679 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Catalyst Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.